Therapeutic Advances in Endocrinology and Metabolism

Papers
(The TQCC of Therapeutic Advances in Endocrinology and Metabolism is 8. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-08-01 to 2026-08-01.)
ArticleCitations
Use of serum MKRN3 and DLK1 levels in precocious puberty: association with an MKRN3 pathogenic variant317
The type 2 deiodinase Thr92Ala polymorphism and cognitive aging: current evidence and biological context213
Insulin therapy among diabetic patients in rural communities of Sub-Saharan Africa: a perspective review65
Controversies in the management of active Charcot neuroarthropathy54
Treatment of osteoporosis in the solid organ transplant recipient: an organ-based approach36
Gender-affirming hormone therapy, mental health, and surgical considerations for aging transgender and gender diverse adults33
Role of epicardial adipose tissue in diabetic cardiomyopathy through the lens of cardiovascular magnetic resonance imaging – a narrative review33
Novel therapeutic targets for metabolism-related diseases: proteomic Mendelian randomization and colocalization analyses29
Leave no bone unturned: metabolic bone disease in special populations26
Glycaemic outcomes in people living with diabetes under 65 and over 65 years old using an intermittently scanned continuous glucose monitoring system25
Differences in adherence to using removable cast walker treatment during daytime and nighttime weight-bearing activities in people with diabetes-related foot ulcers22
Is there a causal relationship between hypothyroidism and hyponatremia?22
Chronic kidney disease combined with metabolic syndrome is a non-negligible risk factor22
Effectiveness of open-source Android artificial pancreas systems for glucose management in patients with type 1 diabetes: a real-world study22
Antidiabetic drug and chronic respiratory disease in type 2 diabetes: a network meta-analysis and Mendelian randomization analysis21
Pheochromocytoma: a changing perspective and current concepts20
Design and rationale for the SIB trial: a randomized parallel comparison of semaglutide versus placebo on intestinal barrier function in type 2 diabetes 19
Diagnostic performance of morning basal serum cortisol for assessing adrenal reserve: a single-center experience from the United Arab Emirates19
Using digital tools to improve diabetes care in India with continuous glucose monitoring18
Determination of the relationship between raftlin, oxidative stress levels, and vitamin D receptor gene polymorphism in diabetic patients18
Risk factor management over two decades in hospitalised patients with chronic limb-threatening ischaemia with and without diabetes mellitus18
Management strategies for patients with insulin allergy at risk of acute complications: experience from a case report16
Limitation of the current Lin-Weiss-Bisceglia criteria in predicting poor prognosis in oncocytic adrenocortical neoplasms of uncertain malignant potential and oncocytoma diagnosed by the Lin-Weiss-Bis16
Prevalence and associated factors of hyperuricemia among Chinese patients with diabetes: a cross-sectional study16
Association between dietary intake of fatty acids, central obesity, and OAB: insights from a prospective cohort for weight management and dietary prevention15
Chronic pancreatitis and pancreatogenic type 3c diabetes risk: a systematic review and meta-analysis15
A study looking at how missed somatropin injections affect growth in children with growth hormone deficiency: a plain language summary of publication15
Role of estrogen in the regulation of central and peripheral energy homeostasis: from a menopausal perspective15
The legacy effect of early HbA1c control on microvascular complications and hospital admissions in type 2 diabetes: findings from a large UK study14
Influence of the occurrence and duration of partial remission on short-term metabolic control in type 1 diabetes: the DIABHONEY pediatric study14
Potential of duodenal mucosal resurfacing in achieving glycemic control in Asians with type 2 diabetes13
Gender-affirming endocrine care for youth with a nonbinary gender identity13
The missing piece in post-transplant bone health: tertiary hyperparathyroidism management12
Temporal patterns of inpatient hypoglycaemia are treatment-dependent12
Impacts of insulin storage and injection techniques intervention on glycemic control among patients with diabetes in northwest Ethiopia: a quasi-experimental study12
Thanks to Reviewers11
Immune cell infiltration in the pancreas of type 1, type 2 and type 3c diabetes11
Analysis of vitamin D nutritional status and disease risk factors in patients with subacute thyroiditis11
The role of supporting and disruptive mechanisms of FT3 homeostasis in regulating the hypothalamic–pituitary–thyroid axis11
Glycogen storage disease type III: a mixed-methods study to assess the burden of disease10
The bidirectional impacts of alcohol consumption and MAFLD for progressive fatty liver disease10
Efficacy and safety of pralsetinib in multiple endocrine neoplasia type 2-associated pheochromocytoma: a case report9
Implications of gender-affirming endocrine care for sports participation9
Multisystem pathology in chronic variable stress: gut–liver–brain axis disruption and the therapeutic promise of magnesium-L-theanine9
The impact of socioeconomic factors, social determinants, and ethnicity on the utilization of glucose sensor technology among persons with diabetes mellitus: a narrative review8
Comparing quality of life in traditional face-to-face visits with a hybrid approach of telemedicine with in-person follow-ups in recent users of advanced closed-loop systems: a randomized controlled c8
Efficacy and safety of tirzepatide in subjects with type 2 diabetes and chronic kidney disease: a prospective, two-arm observational study8
Proteome-wide and network pharmacology integration identifies sunitinib as a potential therapeutic for type 2 diabetes targets8
Age-related markers and predictors of diabetic kidney disease progression in type 2 diabetes patients: a retrospective cohort study8
Therapeutic potential of adiponectin in prediabetes: strategies, challenges, and future directions8
0.42375993728638